Cost-of-illness studies of diabetes mellitus: A systematic review

Charmaine S. Ng, Joyce Y C Lee, Matthias P H S Toh, Yu Ko

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background: Diabetes mellitus (DM) is recognised as a major health problem. Objectives: The aims of this study are two-fold: (1) to describe the methods used in the identified cost-of-illness (COI) studies of DM and (2) to summarise their study findings regarding the economic impact of DM. Methods: This is a systematic review of MEDLINE and Scopus journal articles reporting the cost of type 1 and/or 2 DM that were published in English from 2007 to 2011. Costs reported in the included studies were converted to US dollars. Results: The systematic search yielded 30 articles. The studies varied considerably in their study design, perspective and included cost categories. Estimates for the total annual costs of DM ranged from US$141.6 million to US$174 billion; direct costs ranged from US$150 to US$14,060 per patient per year (pppy) whereas indirect costs ranged from US$39.6 to US$7,164 pppy. Inpatient cost was the major contributor to direct cost in half of the studies that included inpatient costs, physician services and medications. Conclusion: There is a considerable economic burden associated with DM. Future research should focus on improving methods of estimating costs, enhancing the interpretation of study findings and facilitating comparisons between studies.

Original languageEnglish
Pages (from-to)151-163
Number of pages13
JournalDiabetes Research and Clinical Practice
Volume105
Issue number2
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Cost of Illness
Diabetes Mellitus
Costs and Cost Analysis
Inpatients
Economics
Type 1 Diabetes Mellitus
MEDLINE
Type 2 Diabetes Mellitus
Physicians

Keywords

  • Cost analysis
  • Cost of disease
  • Cost-of-illness
  • Diabetes
  • Economic burden
  • Healthcare costs

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Endocrinology

Cite this

Cost-of-illness studies of diabetes mellitus : A systematic review. / Ng, Charmaine S.; Lee, Joyce Y C; Toh, Matthias P H S; Ko, Yu.

In: Diabetes Research and Clinical Practice, Vol. 105, No. 2, 2014, p. 151-163.

Research output: Contribution to journalArticle

Ng, Charmaine S. ; Lee, Joyce Y C ; Toh, Matthias P H S ; Ko, Yu. / Cost-of-illness studies of diabetes mellitus : A systematic review. In: Diabetes Research and Clinical Practice. 2014 ; Vol. 105, No. 2. pp. 151-163.
@article{ec0211d977a5475f8845a1002ec736eb,
title = "Cost-of-illness studies of diabetes mellitus: A systematic review",
abstract = "Background: Diabetes mellitus (DM) is recognised as a major health problem. Objectives: The aims of this study are two-fold: (1) to describe the methods used in the identified cost-of-illness (COI) studies of DM and (2) to summarise their study findings regarding the economic impact of DM. Methods: This is a systematic review of MEDLINE and Scopus journal articles reporting the cost of type 1 and/or 2 DM that were published in English from 2007 to 2011. Costs reported in the included studies were converted to US dollars. Results: The systematic search yielded 30 articles. The studies varied considerably in their study design, perspective and included cost categories. Estimates for the total annual costs of DM ranged from US$141.6 million to US$174 billion; direct costs ranged from US$150 to US$14,060 per patient per year (pppy) whereas indirect costs ranged from US$39.6 to US$7,164 pppy. Inpatient cost was the major contributor to direct cost in half of the studies that included inpatient costs, physician services and medications. Conclusion: There is a considerable economic burden associated with DM. Future research should focus on improving methods of estimating costs, enhancing the interpretation of study findings and facilitating comparisons between studies.",
keywords = "Cost analysis, Cost of disease, Cost-of-illness, Diabetes, Economic burden, Healthcare costs",
author = "Ng, {Charmaine S.} and Lee, {Joyce Y C} and Toh, {Matthias P H S} and Yu Ko",
year = "2014",
doi = "10.1016/j.diabres.2014.03.020",
language = "English",
volume = "105",
pages = "151--163",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Cost-of-illness studies of diabetes mellitus

T2 - A systematic review

AU - Ng, Charmaine S.

AU - Lee, Joyce Y C

AU - Toh, Matthias P H S

AU - Ko, Yu

PY - 2014

Y1 - 2014

N2 - Background: Diabetes mellitus (DM) is recognised as a major health problem. Objectives: The aims of this study are two-fold: (1) to describe the methods used in the identified cost-of-illness (COI) studies of DM and (2) to summarise their study findings regarding the economic impact of DM. Methods: This is a systematic review of MEDLINE and Scopus journal articles reporting the cost of type 1 and/or 2 DM that were published in English from 2007 to 2011. Costs reported in the included studies were converted to US dollars. Results: The systematic search yielded 30 articles. The studies varied considerably in their study design, perspective and included cost categories. Estimates for the total annual costs of DM ranged from US$141.6 million to US$174 billion; direct costs ranged from US$150 to US$14,060 per patient per year (pppy) whereas indirect costs ranged from US$39.6 to US$7,164 pppy. Inpatient cost was the major contributor to direct cost in half of the studies that included inpatient costs, physician services and medications. Conclusion: There is a considerable economic burden associated with DM. Future research should focus on improving methods of estimating costs, enhancing the interpretation of study findings and facilitating comparisons between studies.

AB - Background: Diabetes mellitus (DM) is recognised as a major health problem. Objectives: The aims of this study are two-fold: (1) to describe the methods used in the identified cost-of-illness (COI) studies of DM and (2) to summarise their study findings regarding the economic impact of DM. Methods: This is a systematic review of MEDLINE and Scopus journal articles reporting the cost of type 1 and/or 2 DM that were published in English from 2007 to 2011. Costs reported in the included studies were converted to US dollars. Results: The systematic search yielded 30 articles. The studies varied considerably in their study design, perspective and included cost categories. Estimates for the total annual costs of DM ranged from US$141.6 million to US$174 billion; direct costs ranged from US$150 to US$14,060 per patient per year (pppy) whereas indirect costs ranged from US$39.6 to US$7,164 pppy. Inpatient cost was the major contributor to direct cost in half of the studies that included inpatient costs, physician services and medications. Conclusion: There is a considerable economic burden associated with DM. Future research should focus on improving methods of estimating costs, enhancing the interpretation of study findings and facilitating comparisons between studies.

KW - Cost analysis

KW - Cost of disease

KW - Cost-of-illness

KW - Diabetes

KW - Economic burden

KW - Healthcare costs

UR - http://www.scopus.com/inward/record.url?scp=84906056459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906056459&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2014.03.020

DO - 10.1016/j.diabres.2014.03.020

M3 - Article

C2 - 24814877

AN - SCOPUS:84906056459

VL - 105

SP - 151

EP - 163

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

IS - 2

ER -